Final Thoughts on Management of ADHD
ADHD experts share their final thoughts on the treatment and management of ADHD.
Unmet Needs in Management of ADHD
Drs Feld, Cutler, Mao, and Amann discuss unmet needs in the management of ADHD.
Access to ADHD Treatments
ADHD experts discuss strategies for improving access to ADHD medications for their patients.
Emerging Treatments for Adults With ADHD
ADHD experts discuss novel treatments and unmet needs in pediatric and adult patients.
Pharmacological Properties and Efficacy Data of Amphetamine XR Oral Tablets
Drs Cerulli and Cutler discuss the data and pharmacological properties of amphetamine XR oral tablets.
Amphetamine XR Oral Tablets in Clinical Practice
Panelists discuss the use of amphetamine XR oral tablets in their practice and for which patients they’re using them.
Recent FDA Approvals for ADHD Treatment
Birgit H. Amann, MD, PLLC, discusses 2 recently approved treatment options for ADHD: amphetamine XR oral tablets and viloxazine.
Individualizing ADHD Treatment for Different Patient Populations
Panelists discuss the importance of choosing treatments that are individualized to their patients.
Choosing Between Different ADHD Formulations
Psychiatrists share their approach to choosing between different ADHD medications and formulations.
Different Formulations of ADHD Medications
Dr Feld highlights several formulations that are available to treat ADHD.
Treatment Options for ADHD
Dr Cutler shares treatment options for ADHD.
Treatment Goals and Treatment Selection in ADHD
Dr Amann and other experts discuss importance of carefully weighing patient and parent expectations and goals when choosing treatment.
Factors Guiding Treatment Selection in ADHD
Drs Cerulli and Cutler discuss factors guiding treatment selection in ADHD.
Comorbidities in Patients with ADHD
ADHD experts discuss their approaches to management of ADHD in patients with comorbidities.
Place of Telemedicine in ADHD
Psychiatrists share how they have incorporated telemedicine in the management of ADHD in their clinics.
Clinical Burden of ADHD and Impact on Quality of Life
Panelists share clinical burden of ADHD and how it impacts pediatric, adolescent and adult populations.
Underdiagnosis of Adult ADHD
ADHD experts discuss presentation and underdiagnosis of ADHD in adults.
Attention-Deficit/Hyperactivity Disorders in Pediatric and Adult Populations
Drs Cerulli, Feld, Cutler, Mao, and Amann discuss prevalence and presentation of ADHD in pediatric, adolescent and adult populations.
Novel Agents for the Management of Pediatric and Adult ADHD
Drs Rakesh Jain, Greg Mattingly, David W. Goodman, Birgit H. Amann, and Theresa R. Cerulli, discuss emerging agents in the pipeline for the management of pediatric and adult ADHD.
Role of Viloxazine in Adult ADHD Treatment
David W. Goodman, MD, leads a discussion on the use of viloxazine for the treatment of adults with ADHD.
Managing Patients with ADHD on Viloxazine
Birgit H. Amann, MD, and Greg Mattingly, MD, share strategies for mitigating adverse events with viloxazine in ADHD and its effect on metabolism of drugs.
Using Viloxazine in Clinical Practice for the Management of ADHD
Key opinion leaders in the management of ADHD comment on where they anticipate using viloxazine and other nonstimulants in the ADHD treatment landscape.
Clinical Profile of Viloxazine in the Treatment of ADHD
Greg Mattingly, MD, and David W. Goodman, MD, discuss the recent approval of viloxazine in children and its clinical profile in the pediatric and adult populations in ADHD.
Medication Challenges and Risks for Adult ADHD Treatment
Birgit H. Amann, MD; Rakesh Jain, MD, MPH; Theresa R. Cerulli, MD; and David W. Goodman, MD, share unmet needs and risks in the treatment of adult ADHD.
Safety and Efficacy of Medications for ADHD Management
Dr David W. Goodman reviews the efficacy and tolerability of different classes of medications for the management of ADHD.
Role of Integrative Treatment in Adult ADHD
Rakesh Jain, MD, MPH, explores the role of an integrative treatment approach in regard to nonpharmacological treatment for the management of adult ADHD.
Treatment Selection for Adult ADHD
Rakesh Jain, MD, MPH, leads a discussion on factors that guide treatment selection for adult patients with ADHD.
Impact of Telehealth on the Management of Adult ADHD
Experts in ADHD discuss the benefits and challenges of telehealth on the diagnosis and management of adult ADHD.
Goals of ADHD Treatment
Birgit H. Amann, MD, and Greg Mattingly, MD, review patient and provider goals of treatment and provide insight on evaluating response to treatment for ADHD.
Role of Pediatric ADHD Guidelines in Diagnosis of ADHD
Greg Mattingly, MD; David W. Goodman, MD; Birgit H. Amann, MD; and Theresa R. Cerulli, MD, evaluate the role of pediatric ADHD guidelines and common misconceptions in the diagnosis and treatment of ADHD.
2 Clarke Drive Cranbury, NJ 08512